News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

Courtney Flaherty

Articles by Courtney Flaherty

FDA Approval Sought for Mirdametinib in NF1-PN | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

FDA approval sought for mirdametinib in NF1-PN

ByCourtney Flaherty

March 4th 2024

SpringWorks Therapeutics has initiated a new drug application for mirdametinib in neurofibromatosis type 1-associated plexiform neurofibromas.

Latest Updated Articles

FDA approval sought for mirdametinib in NF1-PN
Published: March 4th 2024 | Updated:

Trending on Contemporary Pediatrics

Long-term outcomes of lentiviral gene therapy for ADA-deficient severe combined immunodeficiency

Study: Child maltreatment rates declined overall, but disparities persisted across sex and race

© 2025 MJH Life Sciences^®

All rights reserved.